logo

For the Inventor, By the Inventor

West Chester, OH, United States of America

Joseph P Burkhart

This inventor holds 33 USPTO granted patents, plus 15 CIPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merrell Pharmaceuticals, Inc., Merrell Dow Pharmaceuticals, Aventis Pharmaceuticals Inc.. Active years: 1986-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph P Burkhart. Retrieved from https://idiyas.com/inventor/joseph-p-burkhart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33

% Patents Active = 87.9

 

Average Co-Inventor Count = 3.5

ph-index = 7

Forward Citations = 175(Granted Patents)


Location History:

  • West Chester, OH (US) (1986 - 2001)
  • Plainfield, IN (US) (1997 - 2006)

Company Filing History:

goldMedal12 out of 194 
 
Merrell Pharmaceuticals, Inc.
 patents
silverMedal11 out of 455 
 
Merrell Dow Pharmaceuticals
 patents
bronzeMedal4 out of 207 
 
Aventis Pharmaceuticals Inc.
 patents
4. 3 out of 4,509 
 
Eli Lilly and Company
 patents
5. 3 out of 236 
 
Hoechst Marion Roussel
 patents

Years Active: 1986-2006

Loading Chart...
Loading Chart...
Areas of Expertise:
Serotonin Agonists
Elastase Inhibitors
Steroid Derivatives
Peptidase Inhibitors
Aromatase Inhibitors
Thrombin Inhibitors
Matrix Metalloproteinase
Fluoroalkyl Compounds
Alpha-Ketoesters
Heterocyclic Steroids
Prodrugs
Endopeptidase Inhibitors
33 patents (USPTO):Explore Patents
1. 7045545 - Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists (2006-05-16),
2. 6967201 - Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists (2005-11-22),
3. 6953788 - 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase (2005-10-11),
4. 6881733 - Serotonergic benzofurans (2005-04-19),
5. 6693072 - Elastase inhibitors (2004-02-17),
6. 6413951 - 20-fluoro-17(20)-vinyl steroids (2002-07-02),
7. 6313161 - 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase, 19-hydroxylase inhibitors and methods of their use in the treatment of estrogen mediated disorders (2001-11-06),
8. 6265381 - Orally-active elastase inhibitors (2001-07-24),
9. 6172044 - Acylated enol derivative of &agr;-ketoesters and &agr;-ketoamides (2001-01-09),
10. 6130315 - Peptidase inhibitors (2000-10-10),
11. 6069232 - Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors (2000-05-30),
12. 6008196 - Perfluoroalkyl ketone inhibitors of elastase and processes for making (1999-12-28),
13. 5977094 - Methods and compositions using .DELTA..sup.16 unsaturated C.sub.17 (1999-11-02),
14. 5972897 - Acylated enol derivatives as prodrugs of elastase inhibitors (1999-10-26),
15. 5965548 - .increment..sup.16 unsaturated C.sub.17 heterocyclic steroids useful as (1999-10-12),

Title: The Inventor Joseph P Burkhart: Pioneering Innovations in West Chester, OH

Introduction: Joseph P Burkhart is a distinguished inventor based in West Chester, Ohio, known for his groundbreaking contributions to various fields.

Latest Patents: Joseph P Burkhart holds several patents in the areas of technology and engineering, showcasing his continuous commitment to innovation.

Career Highlights: With a career spanning over two decades, Joseph P Burkhart has established himself as a visionary inventor, with a keen eye for identifying gaps in the market and developing unique solutions.

Collaborations: Throughout his career, Joseph P Burkhart has collaborated with leading companies and research institutions to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Joseph P Burkhart's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…